Mechanisms and therapy of hepatic fibrosis: report of the AASLD Single Topic Basic Research Conference - PubMed (original) (raw)

Mechanisms and therapy of hepatic fibrosis: report of the AASLD Single Topic Basic Research Conference

S L Friedman et al. Hepatology. 2000 Dec.

No abstract available

PubMed Disclaimer

Similar articles

• Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference.
  Friedman SL, Rockey DC, Bissell DM. Friedman SL, et al. Hepatology. 2007 Jan;45(1):242-9. doi: 10.1002/hep.21459. Hepatology. 2007. PMID: 17187439
• [A brief introduction about the third AASLD Hepatic Fibrosis Single Topic Conference in 2006].
  Zhan YT. Zhan YT. Zhonghua Gan Zang Bing Za Zhi. 2007 Jul;15(7):554-5. Zhonghua Gan Zang Bing Za Zhi. 2007. PMID: 17669256 Chinese. No abstract available.
• [AASLD plenary sessions. Liver fibrosis in the plenary sessions of the AASLD-AGA 2010].
  Kershenobich Stalnikowitz D. Kershenobich Stalnikowitz D. Rev Gastroenterol Mex. 2010 Aug;75 Suppl 1:223-5. Rev Gastroenterol Mex. 2010. PMID: 20959257 Spanish. No abstract available.
• Mechanisms of liver fibrosis resolution.
  Tacke F, Trautwein C. Tacke F, et al. J Hepatol. 2015 Oct;63(4):1038-9. doi: 10.1016/j.jhep.2015.03.039. Epub 2015 Jul 29. J Hepatol. 2015. PMID: 26232376 Review. No abstract available.
• Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic.
  Muddu AK, Guha IN, Elsharkawy AM, Mann DA. Muddu AK, et al. Int J Biochem Cell Biol. 2007;39(4):695-714. doi: 10.1016/j.biocel.2006.10.006. Epub 2006 Oct 7. Int J Biochem Cell Biol. 2007. PMID: 17110155 Review.

Cited by

• Expression profiles of lncRNAs and their possible regulatory role in monocrotaline-induced HSOS in rats.
  Ismail M, Zhang X, Taha R, Elhafiz M, Zhang Q, Yousef BA, Huang X, Jiang Z, Zhang L, Sun L. Ismail M, et al. Front Genet. 2023 Jan 26;14:1041266. doi: 10.3389/fgene.2023.1041266. eCollection 2023. Front Genet. 2023. PMID: 36777738 Free PMC article.
• Liver immunity, autoimmunity, and inborn errors of immunity.
  Parlar YE, Ayar SN, Cagdas D, Balaban YH. Parlar YE, et al. World J Hepatol. 2023 Jan 27;15(1):52-67. doi: 10.4254/wjh.v15.i1.52. World J Hepatol. 2023. PMID: 36744162 Free PMC article. Review.
• Comparison of the effects of cholesterol, palmitic acid, and glucose on activation of human hepatic stellate cells to induce liver fibrosis.
  Mohammadzadeh G, Afarin R, Bavarsad SS, Aslani F, Zadeh SA, Shakerian E. Mohammadzadeh G, et al. J Diabetes Metab Disord. 2022 Jul 19;21(2):1531-1538. doi: 10.1007/s40200-022-01095-z. eCollection 2022 Dec. J Diabetes Metab Disord. 2022. PMID: 36404864 Free PMC article.
• Integrating Network Pharmacology and Experimental Validation to Investigate the Effects and Mechanism of Astragalus Flavonoids Against Hepatic Fibrosis.
  An L, Lin Y, Li L, Kong M, Lou Y, Wu J, Liu Z. An L, et al. Front Pharmacol. 2021 Jan 22;11:618262. doi: 10.3389/fphar.2020.618262. eCollection 2020. Front Pharmacol. 2021. PMID: 33551818 Free PMC article.
• Two-Dimensional-Shear Wave Elastography with a Propagation Map: Prospective Evaluation of Liver Fibrosis Using Histopathology as the Reference Standard.
  Lee DH, Lee ES, Lee JY, Bae JS, Kim H, Lee KB, Yu SJ, Cho EJ, Lee JH, Cho YY, Han JK, Choi BI. Lee DH, et al. Korean J Radiol. 2020 Dec;21(12):1317-1325. doi: 10.3348/kjr.2019.0978. Epub 2020 Jul 27. Korean J Radiol. 2020. PMID: 32729274 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Ovid Technologies, Inc.
  • Wiley

• Medical

  • MedlinePlus Health Information